Autoimmune haemolytic anaemia in a patient with advanced lung adenocarcinoma and chronic lymphocytic leukaemia receiving nivolumab and intravenous immunoglobulin

Immunotherapy

Autoimmune-related bleeding occurring during combined immunotherapy for lung cancer - Case report

Rev Mal Respir.

Eberst G, Lakhzoum W, Tomasini P, Andreotti N, Abcaya J, Mascaux C, Barlesi F

doi: 10.1016/j.rmr.

Immunotherapy

Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature

Mycopathologia.

Oltolini C, Ripa M, Andolina A, Brioschi E, Cilla M, Petrella G, Gregorc V, Castiglioni B, Tassan Din C, Scarpellini P

doi: 10.1007/s11046-018-0291-4.

Hypersensitivity

[Tattoo hypersensitivity reaction in a patient receiving combined BRAF and MEK inhibitors]

Ann Dermatol Venereol.

Rohmer E, Scrivener JN, Schissler C, Cribier B, Lenormand C

doi: 10.1016/j.annder.2019.08.012.

Autoimmune DiseaseRheumatoid Arthritis

Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review

doi: 10.1177/

Melanoma and Skin Cancer

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Br J Dermatol.

Gault A, Anderson AE, Plummer R, Stewart C, Pratt AG, Rajan N

doi: 10.1111/bjd.19750.Visit the original publication at ncbi.nlm.nih.gov

Melanoma and Skin Cancer

[Synergistic effect of anti-PD1 immunotherapy then radiotherapy in advanced basal cell carcinoma]

Ann Dermatol Venereol.

Malmontet T, Dousset L, Gerard E, Ouhabrache N, Pham-Ledard A, Beylot-Barry M

doi: 10.1016/j.annder.2019.08.019.

Melanoma and Skin Cancer

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Melanoma Res.

Thummalapalli R, Melms JC, Mier J, Izar B

doi: 10.1097/CMR.0000000000000646.

Melanoma and Skin Cancer

Paraneoplastic neutrophilic leukemoid reaction in a melanoma patient: association between tumour volume and leukocytosis

Br J Dermatol.

Fredeau L, Bohelay G, Shourick J, Piver D, Guyot A, -H Schlageter M, Caux F, Maubec E

doi: 10.1111/bjd.19059.

Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review

Rheumatol Int.

González-Moreno J, Raya-Cruz M, Losada-Lopez I, Cacheda AP, Oliver C, Colom B

doi: 10.1007/s00296-018-3991-7.

Related content

Autoimmune-related bleeding occurring during combined immunotherapy for lung cancer - Case report

Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature

[Tattoo hypersensitivity reaction in a patient receiving combined BRAF and MEK inhibitors]

Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

[Synergistic effect of anti-PD1 immunotherapy then radiotherapy in advanced basal cell carcinoma]

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Paraneoplastic neutrophilic leukemoid reaction in a melanoma patient: association between tumour volume and leukocytosis

Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review